A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Development and validation of novel rapid stability indicating mass compatible UPLC method for the simultaneous estimation of assay and related substances of oxytocin bulk and assay of injectable dosage form
2022
International Journal of Health Sciences
Developed and validated a simple, rapid, new mass compatible reverse phase ultra-performance liquid chromatography (UPLC) method for the simultaneous estimation of Assay and related substance of Oxytocin in bulk and extending the same method to injectable dosage form for the estimation of Assay. The developed method is capable of separating all the potential process and degradation impurities within 15 minutes. Chromatography was carried out using Waters Acquity CSH C18 column (50 mm length,
doi:10.53730/ijhs.v6ns4.9633
fatcat:tlsfy57icnbx3a4t3sxfzew7tq